Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. (27th June 2018)
- Record Type:
- Journal Article
- Title:
- Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. (27th June 2018)
- Main Title:
- Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study
- Authors:
- Blumenthal, Kimberly G
Lu, Na
Zhang, Yuqing
Li, Yu
Walensky, Rochelle P
Choi, Hyon K - Abstract:
- Abstract: Objective: To evaluate the relation between penicillin allergy and development of meticillin resistant Staphylococcus aureus (MRSA) and C difficile . Design: Population based matched cohort study. Setting: United Kingdom general practice (1995-2015). Participants: 301 399 adults without previous MRSA or C difficile enrolled in the Health Improvement Network database: 64 141 had a penicillin allergy and 237 258 comparators matched on age, sex, and study entry time. Main outcome measures: The primary outcome was risk of incident MRSA and C difficile . Secondary outcomes were use of β lactam antibiotics and β lactam alternative antibiotics. Results: Among 64 141 adults with penicillin allergy and 237 258 matched comparators, 1365 developed MRSA (442 participants with penicillin allergy and 923 comparators) and 1688 developed C difficile (442 participants with penicillin allergy and 1246 comparators) during a mean 6.0 years of follow-up. Among patients with penicillin allergy the adjusted hazard ratio for MRSA was 1.69 (95% confidence interval 1.51 to 1.90) and for C difficile was 1.26 (1.12 to 1.40). The adjusted incidence rate ratios for antibiotic use among patients with penicillin allergy were 4.15 (95% confidence interval 4.12 to 4.17) for macrolides, 3.89 (3.66 to 4.12) for clindamycin, and 2.10 (2.08 to 2.13) for fluoroquinolones. Increased use of β lactam alternative antibiotics accounted for 55% of the increased risk of MRSA and 35% of the increased risk of CAbstract: Objective: To evaluate the relation between penicillin allergy and development of meticillin resistant Staphylococcus aureus (MRSA) and C difficile . Design: Population based matched cohort study. Setting: United Kingdom general practice (1995-2015). Participants: 301 399 adults without previous MRSA or C difficile enrolled in the Health Improvement Network database: 64 141 had a penicillin allergy and 237 258 comparators matched on age, sex, and study entry time. Main outcome measures: The primary outcome was risk of incident MRSA and C difficile . Secondary outcomes were use of β lactam antibiotics and β lactam alternative antibiotics. Results: Among 64 141 adults with penicillin allergy and 237 258 matched comparators, 1365 developed MRSA (442 participants with penicillin allergy and 923 comparators) and 1688 developed C difficile (442 participants with penicillin allergy and 1246 comparators) during a mean 6.0 years of follow-up. Among patients with penicillin allergy the adjusted hazard ratio for MRSA was 1.69 (95% confidence interval 1.51 to 1.90) and for C difficile was 1.26 (1.12 to 1.40). The adjusted incidence rate ratios for antibiotic use among patients with penicillin allergy were 4.15 (95% confidence interval 4.12 to 4.17) for macrolides, 3.89 (3.66 to 4.12) for clindamycin, and 2.10 (2.08 to 2.13) for fluoroquinolones. Increased use of β lactam alternative antibiotics accounted for 55% of the increased risk of MRSA and 35% of the increased risk of C difficile . Conclusions: Documented penicillin allergy was associated with an increased risk of MRSA and C difficile that was mediated by the increased use of β lactam alternative antibiotics. Systematically addressing penicillin allergies may be an important public health strategy to reduce the incidence of MRSA and C difficile among patients with a penicillin allergy label. … (more)
- Is Part Of:
- BMJ. Volume 361(2018)
- Journal:
- BMJ
- Issue:
- Volume 361(2018)
- Issue Display:
- Volume 361, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 361
- Issue:
- 2018
- Issue Sort Value:
- 2018-0361-2018-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-06-27
- Subjects:
- Medicine -- Periodicals
Medicine -- Periodicals
Medicine
Periodicals
610 - Journal URLs:
- http://www.bmj.com/archive ↗
http://www.jstor.org/journals/09598138.html ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/3/ ↗
http://www.bmj.com/bmj/ ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/bmj.k2400 ↗
- Languages:
- English
- ISSNs:
- 0007-1447
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23824.xml